Efficacy and safety of anti-TNF-α therapy combined with cyclosporine a in patients with rheumatoid arthritis and concomitant hepatitis C virus infection

C. Giannitti, M. Benucci, R. Caporali, S. Manganelli, F. Bellisai, G. D. Sebastiani, Mauro Galeazzi

Research output: Contribution to journalArticlepeer-review

Abstract

This study further expands our previous observation demonstrating the usefulness of combination therapy of anti-TNF-alpha and Cyclosporine A in the treatment of rheumatoid arthritis and concurrent hepatitis C virus infection, as well its efficacy and safety in controlling HCV viremia and liver toxicity. Seven patients were included in the study; transaminase levels remained unchanged, HCV RNA serum levels decreased significantly and DAS 28 significantly improved after twelve month follow-up. No side effects were registered.

Original languageEnglish
Pages (from-to)543-546
Number of pages4
JournalInternational Journal of Immunopathology and Pharmacology
Volume22
Issue number2
Publication statusPublished - Apr 2009

Keywords

  • Anti TNF- α
  • CsA
  • HCV
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Fingerprint Dive into the research topics of 'Efficacy and safety of anti-TNF-α therapy combined with cyclosporine a in patients with rheumatoid arthritis and concomitant hepatitis C virus infection'. Together they form a unique fingerprint.

Cite this